Health Care & Pharmaceuticals

Monopoly is a huge factor in driving up prices and driving down quality in America’s health care sector. After waves of hospital mergers, most Americans now live in communities where only one or two hospitals still compete for their health care dollars, and where competition among health care insurers has also largely disappeared. Meanwhile, competition in the pharmaceutical industry is stymied by patent monopolies and highly concentrated corporate ownership.

Benefits Pro: Wanted – More health care competition

Date Published: August 22, 2019

Benefits Pro reporter Scott Woolridge reports that the consolidation of market share in health-related industries has happened largely under the radar. He cites Open Markets’ American Concentration Crisis report and interviews Executive Director Barry Lynn on how consolidation is impacting every day Americans. “This stuff could be fixed by the DOJ and the FTC tomorrow,” he says. “There is an ample amount of power in federal and state governments to address this, it’s just not being used.”

Continue Reading

The Corner Newsletter, July 26, 2019: The Corner Newsletter: Commissioner Chopra’s Powerful Dissent – How Trump’s New Executive Order on Hospital Pricing Could Change Health Care – Three Takeaways from the House Antitrust Subcommittee’s Latest Hearing

Date Published: July 26, 2019

Welcome to The Corner. In this issue, we highlight a powerful dissent in the Federal Trade Commission’s settlement with Facebook, discuss why the Trump Administration’s new hospital pricing rule won’t fix American healthcare, and identify three key takeaways from last week’s House subcommittee hearing on Amazon, Apple, Facebook, and Google.

Continue Reading

Axios: The U.S. health care system is full of monopolies

Date Published: June 10, 2019

Axios reporter Sam Baker publishes an exclusive report on Open Markets’ second volume of concentration data looking at consolidation in healthcare-related industry sectors. “America’s health care crisis is brought you by monopoly,” Open Markets policy director Phil Longman told Axios.

Continue Reading

Open Markets Filed Amicus Brief to Seventh Circuit Court in Support of Plaintiffs in Marion Diagnostic Center v. Becton, Dickinson & Co.

Date Published: April 26, 2019

Open Markets Institute filed an amicus brief to the Seventh Circuit Court in support of the plaintiffs in Marion Diagnostic Center v. Becton, Dickinson & Co. The plaintiffs, who are health care providers, allege that Becton, Dickinson & Co. illegally dominated the markets for conventional syringes, safety syringes, and safety IV catheters.

Continue Reading

Join the Movement

In America today, wealth and political power are more concentrated than at any point in our country’s history.

The Open Markets Institute, formerly the Open Markets program at New America, was founded to protect liberty and democracy from these extreme -- and growing -- concentrations of private power.

Stay updated

Sign up to stay informed.